We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
-4.86%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$16B
AUM Growth
-$1.05B
Cap. Flow
-$192M
Cap. Flow %
-1.2%
Top 10 Hldgs %
35.77%
Holding
1,457
New
38
Increased
735
Reduced
275
Closed
40

Top Buys

Rank Stock Value
1
INVH icon
Invitation Homes
INVH
+$216M
2
CPT icon
Camden Property Trust
CPT
+$180M
3
AMT icon
American Tower
AMT
+$137M
4
PLD icon
Prologis
PLD
+$122M
5
EXR icon
Extra Space Storage
EXR
+$90.4M

Top Sells

Rank Stock Value
1
VTR icon
Ventas
VTR
+$181M
2
AVB icon
AvalonBay Communities
AVB
+$166M
3
HST icon
Host Hotels & Resorts
HST
+$163M
4
REG icon
Regency Centers
REG
+$134M
5
ESS icon
Essex Property Trust
ESS
+$92.2M

Sector Composition

Rank Sector Weight
1 Real Estate 60.21%
2 Technology 9.75%
3 Consumer Discretionary 4.32%
4 Healthcare 3.56%
5 Financials 3.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACRS icon
1176
Aclaris Therapeutics
ACRS
$715M
$3K ﹤0.01%
179
– –
ARQT icon
1177
Arcutis Biotherapeutics
ARQT
$3.48B
$3K ﹤0.01%
172
– –
ATRA icon
1178
Atara Biotherapeutics
ATRA
$72.6M
$3K ﹤0.01%
12
– –
AVXL icon
1179
Anavex Life Sciences
AVXL
$231M
$3K ﹤0.01%
222
– –
BCYC
1180
Bicycle Therapeutics
BCYC
$269M
$3K ﹤0.01%
58
– –
CCCC icon
1181
C4 Therapeutics
CCCC
$389M
$3K ﹤0.01%
142
– –
CHRS icon
1182
Coherus Oncology
CHRS
$217M
$3K ﹤0.01%
262
– –
CRNX icon
1183
Crinetics Pharmaceuticals
CRNX
$8.88B
$3K ﹤0.01%
132
– –
DBC icon
1184
Invesco DB Commodity Index Tracking Fund
DBC
$1.69B
$3K ﹤0.01%
100
– –
DSGN icon
1185
Design Therapeutics
DSGN
$751M
$3K ﹤0.01%
162
– –
ERAS icon
1186
Erasca
ERAS
$6.15B
$3K ﹤0.01%
354
– –
FSLY icon
1187
PUT
Fastly Inc
FSLY
$3.24B
$3K ﹤0.01%
+100
New +$2.33K
FULC icon
1188
Fulcrum Therapeutics
FULC
$241M
$3K ﹤0.01%
138
– –
MNKD icon
1189
MannKind Corp
MNKD
$1.19B
$3K ﹤0.01%
855
– –
MRUS
1190
DELISTED
Merus
MRUS
$3K ﹤0.01%
125
– –
NKTR icon
1191
Nektar Therapeutics
NKTR
$2.39B
$3K ﹤0.01%
36
– –
PMVP icon
1192
PMV Pharmaceuticals
PMVP
$57.1M
$3K ﹤0.01%
132
– –
QURE icon
1193
uniQure
QURE
$2.75B
$3K ﹤0.01%
158
– –
RCKT icon
1194
Rocket Pharmaceuticals
RCKT
$343M
$3K ﹤0.01%
218
– –
REPL icon
1195
Replimune Group
REPL
$454M
$3K ﹤0.01%
160
– –
RNAM
1196
DELISTED
Avidity Biosciences
RNAM
$3K ﹤0.01%
156
– –
SEER icon
1197
Seer Inc
SEER
$114M
$3K ﹤0.01%
166
– –
SGMO
1198
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$3K ﹤0.01%
498
– –
SNDX icon
1199
Syndax Pharmaceuticals
SNDX
$1.7B
$3K ﹤0.01%
167
– –
STOK icon
1200
Stoke Therapeutics
STOK
$1.84B
$3K ﹤0.01%
126
– –
46 47
48
49 50

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Daiwa Securities Group's Q1 2022 Portfolio in Review

As of Q1 2022, Daiwa Securities Group held 1,457 positions worth $16B, down 6.2% from $17B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Daiwa Securities Group's Q1 2022 filing shows 38 new, 735 increased, 275 reduced and 40 closed positions. Its largest new stake was Federal Realty Investment Trust: 21,861 shares worth $2.67M. The largest sale was Ventas, an estimated $181M.

By sector, the portfolio is most concentrated in Real Estate at 60% of assets, down from 60% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Daiwa Securities Group's largest Q1 2022 buy was Federal Realty Investment Trust: 21,861 shares worth $2.67M.
  • Daiwa Securities Group added most to Invitation Homes in Q1 2022, an estimated $216M increase.
  • Daiwa Securities Group's biggest Q1 2022 reduction was Ventas, cutting an estimated $181M.
  • Daiwa Securities Group fully exited Xilinx Inc in Q1 2022, selling an estimated $4.54M.
  • Daiwa Securities Group's ten largest holdings make up 36% of its $16B portfolio in Q1 2022.
  • Daiwa Securities Group opened 38 new positions and closed 40 in Q1 2022.
  • Daiwa Securities Group's portfolio value fell 6.2% quarter-over-quarter to $16B.

Based on Daiwa Securities Group's 13F filing for Q1 2022, filed 29 Apr 2022.